Stockreport

4DMT to Participate in Upcoming Investor Conferences

4D Molecular Therapeutics, Inc.  (FDMT) 
PDF EMERYVILLE, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage company focused on unlock [Read more]